Paul M. Silva, SVP & Controller at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,227 shares at $229.66 ($524K) on 2020-02-25, disclosed to the SEC on 2020-02-26.
Seasonal sale ($524k) by SVP & Controller — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $239.23 | 864 | $207K | 39.5% |
| 2 | $229.66 | 283 | $65K | 12.4% |
| 3 | $229.66 | 283 | $65K | 12.4% |
| 4 | $231.17 | 137 | $32K | 6.0% |
| 5 | $232.40 | 120 | $28K | 5.3% |
| 6 | $234.50 | 150 |
| $35K |
| 6.7% |
| 7 | $235.49 | 150 | $35K | 6.7% |
| 8 | $236.85 | 90 | $21K | 4.1% |
| 9 | $238.40 | 150 | $36K | 6.8% |
| Total | $235.21 avg | 2,227 | $524K | 100% |
| Filing → |
| VRTX | SELL | 2021-02-19 | $1.8M | — | Filing → |
| VRTX | SELL | 2021-02-16 | $586K | — | Filing → |
| VRTX | SELL | 2020-08-10 | $564K | — | Filing → |